Longevity research is shifting from isolated silos toward an integrated model that bridges physical, mental, and emotional health. Central to this evolution is the recognition that lifestyle choices and self-regulation—often impaired by early childhood trauma—significantly impact biological aging. Experts are exploring diverse interventions, ranging from gene therapies like telomerase and folistatin to decentralized drug development via blockchain-based organizations. Simultaneously, the field is grappling with the "evolutionary mismatch" where ancestral survival mechanisms, such as the fight-or-flight response, remain maladaptive in modern society. Establishing robust, aggregate biomarkers for chronic diseases remains a critical challenge for measuring the efficacy of these longevity interventions. By combining neuroplasticity-based healing with data-driven medical strategies, researchers aim to move beyond merely slowing aging to actively reversing its phenotypes and improving overall healthspan.
Sign in to continue reading, translating and more.
Open full episode in Podwise